시장보고서
상품코드
2132882

미세다공성 폴리에테르설폰 막 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Microporous Polyethersulfone Membrane Market Report: Trends, Forecast and Competitive Analysis to 2035

발행일: | 리서치사: 구분자 Lucintel | 페이지 정보: 영문 150 Pages | 배송안내 : 3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF, Excel & 1 Year Online Access (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,850 금액 안내 화살표 ₩ 6,615,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF & Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,700 금액 안내 화살표 ₩ 9,139,000
PDF, Excel & 1 Year Online Access (Corporate License) help
PDF & Excel 보고서를 동일 기업 내 동일 국가의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,850 금액 안내 화살표 ₩ 12,072,000
PDF, Excel & 1 Year Online Access (Global License) help
PDF & Excel 보고서를 동일 기업(완전 자회사 포함)의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 13,641,000
※ 부가세 별도
한글목차
영문목차

미세다공성 폴리에테르설폰 막 시장

세계 미세다공성 폴리에테르설폰 막 시장의 전망은 음용수·폐수처리, 식품·음료 및 바이오의약품 시장의 성장 기회로 인해 유망할 것으로 예상됩니다. 전 세계 미세다공성 폴리에테르설폰 막 시장은 2027년 3억 9,300만 달러에서 2035년까지 약 6억 3,100만 달러에 달할 것으로 예상되며,2027년부터 2035년까지 연평균 성장률(CAGR)은 8.1%에 달할 전망입니다. 이 시장의 주요 성장 촉진요인은 수처리 및 폐수처리 솔루션에 대한 수요 증가와 바이오의약품 및 헬스케어 산업의 확대입니다.

  • Lucintel의 예측에 따르면, 유형별로는 더 얇은 포일을 사용한 콤팩트하고 고밀도의 기판 설계가 채택됨에 따라, 10-500kd 범주가 예측 기간 동안 가장 높은 성장률을 보일 것으로 전망됩니다.
  • 용도별로는, 더욱 가볍고 얇은 컴퓨팅 기기에 대한 수요가 증가함에 따라 음용수·폐수처리 분야가 예측 기간 동안 가장 높은 성장률을 보일 것으로 전망됩니다.
  • 지역별로는, 아시아태평양(APAC) 지역의 전기자동차 수요 확대에 힘입어 예측 기간 동안 해당 지역에서 가장 높은 성장이 예상됩니다.

미세다공성 폴리에테르설폰(PES) 막 시장의 새로운 동향

미세다공성 폴리에테르설폰 막 시장은 2027년까지 범용 여과에서 보다 복잡하고 용도 특화형 시스템으로 전환될 것으로 전망됩니다. 이는 의약품 규제의 강화와 더불어, 바이오프로세싱 능력의 확대, 물 재이용 기술에 대한 투자, 그리고 공급망 내 리스크 관리에 대한 집중 강화와 같은 요인들이 뒷받침하고 있습니다. Lucintel은 이를 추출물이 적고, 규모 확대 시 신뢰성이 높은 균일한 기공 구조를 가진 막으로의 큰 흐름의 일부로 보고 있습니다.

  • 지속가능성 : 2027년까지 제약 제조업체들은 물 재이용 프로젝트에 대한 발주를 늘릴 것이며, 유럽에서 PFAS에 대한 규제 압력이 강화됨에 따라 첨단 분리 기술에 대한 관심이 높아질 것입니다. 이 기간 동안 용매 소비량을 줄이고 저에너지 운영을 촉진하는 공정용 막이, 폐기물이 많이 발생하는 일회용 제품보다 우선시될 것입니다.
  • 디지털 제조 : 각 공급업체는 인라인 무결성 테스트, 머신비전, SPX 도입을 추진하고 있습니다. 2025년 1월, 바이오의약품 제조사들은 여과 공정에서의 데이터 무결성을 계속해서 중시하고 있었습니다. 이에 따라 2020년대에는 디지털 추적성이 배치의 일관성, 적합성 평가 및 고객 전환에 영향을 미치게 될 것입니다.
  • 바이오의약품의 확대 : 일회용 시스템에 더해, 강화 처리의 활용 확대에 따라 멸균 등급 폴리에테르설폰(PES) 막에 대한 수요가 견인되고 있습니다. 2024년 바이오의약품 매출액은 4,000억 달러를 넘어설 것으로 추정되며, 이 기간 동안 막 공급업체에게는 더 많은 기회가 생길 것입니다.
  • 지역별 공급망 다각화 : 팬데믹으로 인한 막 공급 상황에 영향을 받아 민간 제약사들은 아시아태평양(APAC), EU, 북미(NA) 지역에서 2차 공급업체를 확보하고 있습니다. 2025년 중국의 제약 제조 성장은 현지 수요를 충족하기 위한 막 기술의 전환을 촉진할 것입니다.
  • 기능 중심의 설계 : 고객들은 기존의 미세다공성 매체에서 서로 다른 비대칭 구조, 낮은 단백질 결합성을 지닌 표면, 그리고 특정 기공 직경을 가진 제품으로 전환하고 있습니다. 2025년부터 2027년까지, 맞춤형 0.2마이크론 멸균 여과는 바이오프로세싱 분야에서 핵심 요건으로 남아 있을 것입니다. 타사와 차별화된 성능이야말로, 표준 막의 가격이 하락할 것으로 예상되는 상황에서도 이익률을 유지할 수 있는 기회를 제공할 것입니다.

미세다공성 폴리에테르설폰(PES) 막 시장의 성장은 판매량 확대보다는 특수한 여과 용도에 기인할 것입니다. 경쟁의 향방은 제약 업계의 검증, 물 재이용, 디지털 품질 관리 시스템, 그리고 지역 공급업체로부터의 조달에 의해 결정될 것입니다. 애플리케이션 엔지니어링과 신뢰할 수 있는 막 화학 기술은 기업이 고객을 유지하는 데 도움이 될 것입니다. 바이오프로세싱 및 산업용 수처리 분야에서 비용은 구매 시 가장 중요한 요소이지만, 고장 위험의 증가와 규제 관련 문서의 복잡화도 점점 더 중요해지고 있습니다.

미세다공성 폴리에테르설폰 막 시장의 최근 동향

바이오의약품 생산능력에 대한 투자 확대, 무균 제조 요건의 강화, 그리고 수처리 투자 증가를 배경으로 미세다공성 폴리에테르설폰 막에 대한 수요가 증가하고 있습니다. Lucintel사는 추출물이 적은 고처리량 막에 대한 수요가 높아질 것으로 예측하고 있습니다. 공급업체는 밸리데이션 지원 및 특정 형식에 대응하는 막을 제공하는 동시에, 단순히 기공 크기에 기반한 가격 책정에 그치지 않고 더 광범위한 용도를 고려해야 합니다.

  • 바이오 공정 생산능력 확대 : 살토리아스(Sartorius)사는 2025년 1월, 독일에 위치한 막 여과 시설 확장에 1억 유로를 투자할 예정입니다. 이를 통해 향후 3-5년까지 일회용 바이오 공정 공급에 긍정적인 영향을 미칠 것으로 보입니다.
  • 지역별 제조 투자 : 머크(Merck)의 라이프사이언스 부문은 다른 지역에서 구축한 생산능력에 더해, 2025년에 여과 제품의 실험실 규모 제조를 확대하여 리드타임을 단축할 예정입니다. 이를 통해 제약사는 공급 안정성 요건을 충족할 수 있게 될 것입니다.
  • 첨단 막 : 2025년에는 폴(Paul)사를 비롯한 각 여과 공급업체들이 바이러스 제거 및 무균 여과용 고표면적 PES 막을 출시할 전망입니다. 이러한 막은 처리 시간과 공정 수를 대폭 줄일 가능성이 있습니다.
  • 수처리 분야의 제휴 : 2025년, 산업용 수처리 분야 기업들은 한외여과와 역삼투를 결합한 시스템에서 PES 막을 우선적으로 선택할 전망입니다. 내화학성과 세척 공정의 조합을 통해 PES 막은 상수도 및 산업용 수처리 분야에서 더욱 폭넓은 용도로 활용될 것으로 기대됩니다.
  • 규제 주도형 검증 : 2025년 지침 및 감사에서 의약품 규제 당국은 계속해서 추출물, 용출물 및 공정 오염 관리에 중점을 둘 것입니다. 제조업체들이 구매 평가의 일환으로 문서화와 배치 간 일관성을 점점 더 중요시함에 따라, 종합적인 검증 패키지를 제공하는 공급업체는 지속적으로 더 많은 계약을 수주하게 될 것입니다.

향후 5년 동안 시장은 주로 바이오의약품 제조와 물 재사용을 원동력으로 삼아 꾸준히 성장할 것으로 예상됩니다. 표준 막의 경우 여전히 치열한 가격 경쟁이 지속될 것이지만, 추출물 함량이 낮은 검증 완료 제품은 더 높은 수익성을 기대할 수 있을 것입니다. 공정 변경 외에도 공급업체는 생산능력 확충, 지역별 공급망 구축, 그리고 자동화 도입을 추진해야 합니다. 기공 구조 개선이 가져오는 효과는 기껏해야 점진적인 수준에 그칠 것입니다. 공급업체는 단순한 실험실 규모의 성능뿐만 아니라 생산 규모의 성능도 제공해야 할 것입니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 미세다공성 폴리에테르설폰 막 시장 : 유형별

제5장 세계의 미세다공성 폴리에테르설폰 막 시장 : 용도별

제6장 지역별 분석

제7장 북미의 미세다공성 폴리에테르설폰 막 시장

제8장 유럽의 미세다공성 폴리에테르설폰 막 시장

제9장 아시아태평양의 미세다공성 폴리에테르설폰 막 시장

제10장 RoW의 미세다공성 폴리에테르설폰 막 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체의 주요 기업 개요

제14장 부록

KSM 26.09.29

Microporous Polyethersulfone Membrane Market

The future of the global microporous polyethersulfone membrane market looks promising with opportunities in the drinking water & wastewater treatment, food & beverage, and biopharmaceutical markets. The global microporous polyethersulfone membrane market is expected to reach an estimated $631 million by 2035 from $393 million in 2027 with a CAGR of 8.1% from 2027 to 2035. The major drivers for this market are the growing demand for water and wastewater treatment solutions and the expansion of biopharmaceutical and healthcare industries.

  • Lucintel forecasts that, within the type category, the 10-500kd is expected to witness the highest growth over the forecast period due to more compact high density substrate designs with thinner foil.
  • Within the application category, drinking water & wastewater treatment is expected to witness the highest growth over the forecast period due to greater demand for lighter, thinner computing devices.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to greater demand for electric vehicles in this region.

Emerging Trends in Microporous Polyethersulfone Membrane Market

The microporous polyethersulfone membrane market will shift from commodity filtration to more complex, application-specific systems by 2027, driven by more stringent pharmaceutical regulations and other factors, including more bioprocessing capacity, investment in water-reuse technology, and a greater focus on managing risk in the supply chain. Lucintel views this as part of a greater trend toward membranes of consistent pore structure with fewer extractables and greater reliability during scale-up.

  • Sustainability: By 2027, pharmaceutical manufacturers will award more contracts for water reuse projects and increasing regulatory pressure on PFAS in Europe will drive interest in advanced separation. During this time, process membranes that reduce solvent consumption and promote low energy operations will gain preference over waste intensive, disposable alternatives.
  • Digital Manufacturing: Suppliers are implementing inline integrity tests, machine vision, and SPX. In January 2025, biopharmaceutical manufacturers continued to emphasize data integrity during filtration. Based on this, digital traceability will influence batch consistency, qualification, and switching of customers during the 2020s.
  • Biopharmaceutical Expansion: The single use systems along with the growing use of intensified processing are driving demand for sterilizing grade polyethersulfone membranes. The sales of biologics were estimated to be greater than $400 billion in 2024 and will create additional opportunities for membrane suppliers during this time.
  • Regional Supply Chain Diversification: Private pharmaceutical manufacturers are sourcing second tier suppliers from the APAC, EU, and NA regions following the impact of the pandemic on membrane availability. The growth of China's pharmaceutical manufacturing in 2025 will reinforce the conversion of membrane technology to meet the local needs.
  • Design for Function: Customers are moving away from the typical microporous media toward different asymmetric structures, low protein-binding surfaces, and pore ratings. Customized 0.2-micron sterilizing filtration will remain a core requirement in bioprocessing in the period from 2025 to 2027. Distinguishable performance offers the opportunity to maintain margins during the projected price decline for standard membranes.

The growth of the microporous polyethersulfone membrane market will come through specialized filtration rather than volume. Competition will be determined by pharmaceutical validation, water reuse, digital quality systems, and sourcing from regional suppliers. Application engineering and reliable membrane chemistry will help companies retain customers. In bioprocessing and industrial water treatment, cost is the most important factor for purchasing, however, increasing risk of failure and the complexity of regulatory documentation are also becoming more important.

Recent Developments in the Microporous Polyethersulfone Membrane Market

Demand for microporous polyethersulfone membranes is growing as a result of increased investment in biopharmaceutical capacity, increased requirements for sterile manufacturing, and increased investment in water treatment. Lucintel forecasts a growing preference for high-throughput membranes with low extractables. Suppliers will need to offer validation support and membranes in specific formats and will need to consider a broader scope of applications rather than pricing strictly based on pore size.

  • Bioprocessing Capacity Expansion: Sartorius will finance a €100 million expansion of its membrane-based filtration goal in Germany in January 2025. This will make a positive impact on the supply of single-use bioprocessing over the next three to five years.
  • Regional Manufacturing Investment: Merck's Life Science division is extending its Laboratory Manufacturing of Filtration Products in 2025, in addition to the capacity it has built in other regions, to produce products with a shorter lead time. Drug manufacturers will be able to satisfy the supply-security requirements.
  • Advanced Membranes: In 2025, Pall and other filtration suppliers are expected to launch higher-area PES membranes for viral clearance and sterile filtration. These membranes have the potential to significantly reduce the processing time and the number of steps involved.
  • Water-treatment Partnerships: PES membranes are the preferred choice of industrial water companies for their collaboration of ultra-filtration and reverse osmosis in 2025. The combination of chemical resistance and cleaning processes is expected to provide a wider range of applications of PES membranes in municipal water and industrial water.
  • Regulatory-driven Validation: In 2025 guidance and inspections, pharmaceutical regulators continued placing an emphasis on extractables, leachables, and process-contamination control. Suppliers who offer complete validation packages will receive more contracts on an ongoing basis, as manufacturers increasingly consider both documentation and batch consistency as part of their purchasing assessments.

During the next 5 years, the market is projected to grow steadily, primarily driven by the manufacturing of biologics and water reuse. Standard membranes will continue to have intense price competition, while validated products with low extractables will provide better profit potential. Beyond process changes, suppliers will need to implement capacity additions, regional supply chains, and automation. Pore structure refinements will have an incremental effect at best. Suppliers will need to provide production scale performance, as opposed to just lab scale performance.

Strategic Growth Opportunities in the Microporous Polyethersulfone Membrane Market

The projection period of 2024 to 2026 will constrict market space due to the anticipated growth of biopharmaceutical capacities, increased expectations for process-related sterility, and market demand for decreased risk in processes. Lucintel expects the industry's focus to shift for value differentiation to move beyond commodity filters to validated application-specific systems and recurring service value.

  • Single-use Bioprocessing: With the FDA citing 24 biosimilar approvals in the previous 12 months in June 2025, there will be greater adoption of disposable filtration in the coming three to five years. PES membranes designed for cellular and gene therapy should have increased profit margins over this period.
  • Advanced Vaccine Manufacturing: Per the February 2025 WHO update, more than 100 vaccine candidates under development globalize should drive adoption of membranes and modules that offer low protein binding.
  • High-purity Water Systems: The European Commission retained EU GMP pharmaceutical water compliance requirements in March 2025, promoting the replacement of standard filtration technologies with PES membranes that meet GMP requirements at contract manufacturing and formulation facilities.
  • Semiconductor Ultrapure Water: SEMI's estimation of a $697 billion semiconductor industry for 2025, made in December 2024, should drive growth for microporous PES membranes in filtration applications requiring consistent particle control and lower extractables.
  • Regional Manufacturing Expansion: India's pharmaceutical exports in the fiscal year 2024-2025 were $27.9 billion, reported in April 2025. Local technical support, modular skids, and application qualification should enable membrane producers to generate revenues beyond the import of cartridges in South Asia.

Opportunities in the market lie close to production that's regulated. Failure costs are greater than filter-price gaps. Developers should put a priority on extractables data, scalable pore structures and validated packages. Distributors need to offer local service and not just inventory. The replacement demand that is recurring along with qualification switching will lead to supplier selection within three to five years for those that have competitive membrane performance and know-how and reliable delivery.

Microporous Polyethersulfone Membrane Market Drivers and Challenges

The growth of the microporous polyethersulfone membrane market is impacted by the mixed nature of technologies, healthcare, industry, the environment, and regulations. In the opinion of Lucintel, filtration performance, production economics, and market scope will determine the future. On the other hand, volatility of the supply chain, qualification requirements, energy use, and market competition will limit the use of microporous polyethersulfone membranes in the pharmaceutical, water treatment, food, and other industrial processes.

The factors responsible for driving this market include:

  • Need for Innovation: High demand for membranes of narrow pore size distribution, high fouling resistance and chemical compatibility, has induced the development of advanced polyethersulfone and composite membranes. For the 2025 pharmaceutical market, specifications mandating validated bacterial retention have strengthened the demand for high quality sterile grade membranes. Innovation in surface modifications, asymmetric membrane designs and single use, disposable membranes will serve the fast growing biologics, vaccines and diagnostics, as well as higher purity and continuous process streams.
  • Pharmaceutical and Biotechnology Demand: The manufacturing of biopharmaceuticals requires many steps of processing which is enabled by the use of highly reliable sterile grade membranes for cell culture media, buffers, and formulations. The 2025 global manufacturing of pharmaceuticals continued to expand biologics capacity, creating an additional demand for membrane systems. This driver is projected to impact the market since strict controls on contamination, increased biologics vaccine production and the adoption of continuous bioprocessing will result in the continuous demand of polyethersulfone membranes of low extractable grade throughout the duration of the entire biopharmaceutical manufacturing process, from research to commercial.
  • Water and Wastewater Treatment: Microporous polyethersulfone ('PES') membranes support the clarification, pretreatment, and high-purity water production due to their robust mechanical stability and broad chemical resistance. In June 2025, the World Health Organization reported that billions of people still did not have access to safely managed water services, demonstrating the ongoing need for filtration. It is expected that, in the next three to five years, increasing urbanization, industrial water reuse, desalination, and more stringent discharge regulations will create more demand for robust membrane modules and their replacements.
  • Sustainability and Resource Efficiency: There is a growing preference for lower material use, longer membrane life, lessened need for cleaning, and greater water recovery by both membrane manufacturers and their customers. In September 2025, industrial sustainability programs began focusing on reductions of at least 20% for process water use, spurring adoption of more efficient filtration technologies. This will bring market opportunity for polyethersulfone membranes due to their small system footprint, low chemical use, and high process water yield; however, suppliers will have to make more environmentally benign membranes if they wish to improve both the sustainability and resource efficiency of their products.
  • Manufacturing Efficiency and Cost Advantages: Advancements in extrusion, phase-inversion control, automation, and quality inspection are improving membrane consistency at lower defects and costs. In February 2026, high-resolution (<50 micrometers) quality control inspection machines became more commonplace in advanced filtration manufacturing, supporting improved quality control in membrane manufacturing. In the next three to five years, scale economies and process optimization will afford microporous polyethersulfone membranes for a growing number of applications such as food processing, the electronics industry, laboratory use, and water treatment.

The challenges facing this market include:

  • Raw Material and Supply Chain Volatility: Polyethersulfone, and specialized support materials, can increase in price, be subject to transport delays, or be available on a regional basis. As of April 2025, chemical markets worldwide continued to struggle with disruptions to shipping which caused extended delivery lead times on certain trade lanes by several weeks. This challenge will affect the market because unpredictable input costs can reduce margins, slow delivery of goods to customers, and induce customers to evaluate and purchase alternative polymers from other sources which typically increases procurement cost and slows the initiation of new projects.
  • Validation and Regulatory Complexity: Pharmaceutical and medical applications require many different tests such as sterility, extractables, leachables, integrity, and batch reproducibility. By October 2025, control of critical filtration parameters was an extension of quality initiatives in regulated manufacturing and required documented control of these parameters through the lifecycle of the product. Over the next three to five years, the requirements will enhance product quality, increase time to market, and elevate industry costs. Smaller competitors will tend to lose market position to large suppliers that possess validated manufacturing systems, extensive supporting documentation, and expertise in global regulations.
  • Fouling, Energy Use, and Disposal: Fouling of membranes decreases flow and increases energy use, and disposal may become more difficult. In July 2026, industrial water projects began to focus on reducing energy consumption by at least 15% as a way to improve the economics of such projects. This challenge affects the market in that customers choose competing membranes or hybrid technologies when polyethersulfone membranes require frequent replacement, intensive pretreatment, difficult cleaning, and costly end-of-life disposal.

The need for improved filtration technologies in the pharmaceutical industry, along with reuse of wastewater, biotechnology, and high-purity processing will propel the microporous polyethersulfone membranes market. Easier manufacturing, better sustainability, and lower cost of ownership will lead to greater market penetration. Sale of premium products based on performance can also be realized. Barriers to market growth can include issues related to manufacturing, such as volatility of feedstock, stringent approvals, energy consumption, and fouling. The dissipation of waste membranes can also be an issue. During the forecast period, the highest demand for these membranes is likely to be met by suppliers capable of sustaining competitive costs and lowering the cost of ownership, improving durability and consistency of supply, and providing stronger lifecycle documentation.

List of Microporous Polyethersulfone Membrane Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microporous polyethersulfone membrane market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microporous polyethersulfone membrane market companies profiled in this report include-

  • Sartorius
  • DuPont
  • Mann+Hummel
  • Repligen
  • GVS
  • Cytiva
  • 3M
  • Toray
  • Merck
  • Dorsan

Microporous Polyethersulfone Membrane Market by Segment

The study includes a forecast for the global Microporous Polyethersulfone Membrane by type, application, and region.

Microporous Polyethersulfone Membrane Market by Type [Value ($M) from 2019 to 2035]:

  • 10-500kD
  • 0.02-0.2µm
  • 0.2-1µm
  • Others

Microporous Polyethersulfone Membrane Market by Application [Value ($M) from 2019 to 2035]:

  • Drinking Water & Wastewater Treatment
  • Food & Beverage
  • Biopharmaceutical
  • Others

Microporous Polyethersulfone Membrane Market by Region [Value ($M) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Microporous Polyethersulfone Membrane Market

Microporous polyethersulfone (MPES) membranes have experienced market growth due to recent investment in pharmaceutical filtration, shifts in regional supply chain policies, and more stringent manufacturing processes. As per Lucintel's finding, upcoming challenges and activities for the years 2025 to 2027 will focus on building resilient capacity for single-use processing and establishing locally manufactured filtration systems in prominent biomanufacturing economies.

  • United States: The growth of domestic biomanufacturing and increased sourcing of process equipment by Danaher companies has spurred the incipient establishment of additional filtration capacity within the United States. In January of 2025, the U.S. Department of Health and Human Services (HHS) awarded $56 million for the U.S. BIOBUILDER workforce development and manufacturing infrastructure program. This initiative will drive demand for PES sterilizing grade and virus-retentive filters in the U.S. for the next 3 to 5 years.
  • China: Localized membrane production by Chinese pharmaceutical equipment suppliers is indicative of procurement preference for domestically sourced vendors. In March of 2025, Sartorius reported continuing investments in their localized production and application footprints (approximately 20 sites) in China. This combination of local production and customer qualification will ultimately increase the supply of PES filtration assemblies from the local market.
  • Germany: High purity filtration remains dominated by manufacturing in Germany from the investments of Sartorius, Merck, and other process technology suppliers. In June of 2025, Sartorius stated their Gottingen site was employing 4,000 personnel and continued to build out bioprocess manufacturing. This further solidifies Germany's supply of PES membranes for international pharmaceutical supply chains.
  • India: The partnerships and increased biopharmaceutical activity by local producers in filtration and single-use systems by India are enabling their biopharmaceutical expansion. In February 2025, the Indian government approved a ₹1,000-crore biotechnology manufacturing plan under the BioE3 policy, which is expected to create additional capacity to qualify locally produced PES membranes for use in vaccines, biologic products, and as contract manufacturers.
  • Japan: Japanese suppliers are combining their membrane technologies with advanced water and bioprocess technologies. In April 2025, Asahi Kasei made further investments in the development of its membrane business with over 49,000 group employees. These investments will help satisfy the domestic market for high quality PES membranes used in the pharmaceutical and ultrapure water industries.

Features of the Global Microporous Polyethersulfone Membrane Market

  • Market Size Estimates: microporous polyethersulfone membrane market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: microporous polyethersulfone membrane market size by type, application, and region in terms of value ($B).
  • Regional Analysis: microporous polyethersulfone membrane market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the microporous polyethersulfone membrane market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microporous polyethersulfone membrane market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the microporous polyethersulfone membrane market by type (10-500kd, 0.02-0.2µm, 0.2-1µm, and others), application (drinking water & wastewater treatment, food & beverage, biopharmaceutical, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Microporous Polyethersulfone Membrane Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 10-500kD: Trends and Forecast (2019-2035)
  • 4.4 0.02-0.2µm: Trends and Forecast (2019-2035)
  • 4.5 0.2-1µm: Trends and Forecast (2019-2035)
  • 4.6 Others: Trends and Forecast (2019-2035)

5. Global Microporous Polyethersulfone Membrane Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Drinking Water & Wastewater Treatment: Trends and Forecast (2019-2035)
  • 5.4 Food & Beverage: Trends and Forecast (2019-2035)
  • 5.5 Biopharmaceutical: Trends and Forecast (2019-2035)
  • 5.6 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Microporous Polyethersulfone Membrane Market by Region

7. North American Microporous Polyethersulfone Membrane Market

  • 7.1 Overview
  • 7.2 North American Microporous Polyethersulfone Membrane Market by Type
  • 7.3 North American Microporous Polyethersulfone Membrane Market by Application
  • 7.4 United States Microporous Polyethersulfone Membrane Market
  • 7.5 Mexican Microporous Polyethersulfone Membrane Market
  • 7.6 Canadian Microporous Polyethersulfone Membrane Market

8. European Microporous Polyethersulfone Membrane Market

  • 8.1 Overview
  • 8.2 European Microporous Polyethersulfone Membrane Market by Type
  • 8.3 European Microporous Polyethersulfone Membrane Market by Application
  • 8.4 German Microporous Polyethersulfone Membrane Market
  • 8.5 French Microporous Polyethersulfone Membrane Market
  • 8.6 Spanish Microporous Polyethersulfone Membrane Market
  • 8.7 Italian Microporous Polyethersulfone Membrane Market
  • 8.8 United Kingdom Microporous Polyethersulfone Membrane Market

9. APAC Microporous Polyethersulfone Membrane Market

  • 9.1 Overview
  • 9.2 APAC Microporous Polyethersulfone Membrane Market by Type
  • 9.3 APAC Microporous Polyethersulfone Membrane Market by Application
  • 9.4 Japanese Microporous Polyethersulfone Membrane Market
  • 9.5 Indian Microporous Polyethersulfone Membrane Market
  • 9.6 Chinese Microporous Polyethersulfone Membrane Market
  • 9.7 South Korean Microporous Polyethersulfone Membrane Market
  • 9.8 Indonesian Microporous Polyethersulfone Membrane Market

10. ROW Microporous Polyethersulfone Membrane Market

  • 10.1 Overview
  • 10.2 ROW Microporous Polyethersulfone Membrane Market by Type
  • 10.3 ROW Microporous Polyethersulfone Membrane Market by Application
  • 10.4 Middle Eastern Microporous Polyethersulfone Membrane Market
  • 10.5 South American Microporous Polyethersulfone Membrane Market
  • 10.6 African Microporous Polyethersulfone Membrane Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Microporous Polyethersulfone Membrane Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Sartorius
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Dupont
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Mann+Hummel
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Repligen
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 GVS
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Cytiva
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 3M
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Toray
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Merck
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Dorsan
    • Company Overview
    • Microporous Polyethersulfone Membrane Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기